MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market
The closing of the Offering is expected to occur on August 3, 2021, subject to customary closing conditions.
- The closing of the Offering is expected to occur on August 3, 2021, subject to customary closing conditions.
- Cowen, Stifel and William Blair are acting as joint book-running managers for the Offering and as representatives of the underwriters for the Offering.
- In connection with the Offering, MaxCyte has adopted amended and restated Bylaws (the "Bylaws"), which will take effect immediately before the closing of the Offering.
- A copy of the Bylaws will be publicly filed and made available to both Nasdaq and AIM shareholders upon closing of the Offering.